Table 3.

Categorized iron dosing January 1, 1994 to June 30, 1994 by patient characteristics (%)a

CategoryNoneLow (0 to 1000 mg)High (>1000 mg)P
    Native American50.023.826.20.13
    Asian68.116.915.0
    Black63.619.617.1
    White61.420.518.1
Peripheral vascular disease
    no63.519.816.60.001
    yes58.820.720.5
Smoker
    no63.419.317.30.012
    yes59.122.318.6
Able to transfer independently
    no61.120.318.60.46
    yes62.420.017.6
History of diabetes
    no64.919.415.7<0.001
    yes58.421.020.6
Gender
    male64.018.517.50.02
    female60.521.617.9
Transplant before December 31, 1993
    no62.220.017.80.68
    yes63.120.016.9
Average change in BUN <62
    no61.020.718.30.05
    yes64.019.216.8
Hospitalized during baseline period
    no63.819.217.00.017
    yes60.421.118.5
Received EPO at baseline
    no62.421.316.20.41
    yes62.017.520.5
Albumin
    <3.560.321.018.70.16
    3.5 to 462.019.518.5
    >463.820.615.6
Creatinine
    <7.560.419.320.30.06
    7.5 to 12.561.421.317.3
    >12.564.918.216.9
Age (yr)
    18 to 4061.619.319.10.76
    40 to 6061.919.918.2
    >6062.520.317.2
CAD
    no63.019.817.20.26
    yes61.520.318.2
Heart disease
    no64.119.116.80.06
    yes61.120.718.2